AUG 15, 2016 – VANCOUVER - The Top 10 finishers in the 2016 INTERFACE Health Challenge X have been selected. INTERFACE Health Challenge X is the world’s only annual competition to discover the world’s best digital health innovators.

This year's challenge started on March 1st at HiMSS 2016 in Las Vegas with this Call to discover the world's best digital health innovators.

OBIO CAAP Companies Medella Heath & Shift Health were among the finalists, as well as Pre-CAAP comapny NERv Technology. 

For the full article, click here

Former OBIO CAAP company MyndTec's MyndMove™ was highlighted on CTV News regarding brain-controlled robots helping paralyzed patients move again and the newly release study by Duke University, published in Nature.

MyndMove is already in use for upper body rehabilitation in parts of Canada.

"We have seen dramatic improvement in stroke and spinal cord patients,” said brainchild of MyndMove, Dr. Milos R. Popovic, the Toronto Rehab Institute Chair in Spinal Cord Injury Research and Professor in the Institute of Biomaterials and Biomedical Engineering at the University of Toronto.

For the video, click here

For the full text of the Duke study, click here

Congratulations to OBIO Pre-CAAP company iMerciv on being selected to compete at this years CNE Innovation Garage from August 19th - 21st (Enercare Centre at the CNE). 25 innovators from across the province will come together to compete in 5 categories for $25,000 Grand Prize!

The iMerciv BuzzClip is an assistive device that caters to the orientation & mobility needs of blind, deaf-blind and visually impaired communities around the globe. 

The Bio-tech Competition takes place: Friday August 19 @ 3pm. Remember to tweet and use the hashtag #cdntech

Learn more about the CNE Innovation Garage here

Stay Away from Me...I Am Sick

OBIO Pre-CAAP Company iamsick.ca knows that the last thing you want to do when you are sick is look for a family doctor, a walk-in-clinic or a nearby pharmacy.  The new app informs patients on what clinics are nearby (in your actual area) and pharmacies and to find out what clinics are accepting new patients (great when you move to a new area!) and book appointments online.

For the full article click here

Komodo's TECLA technology is making the wildly popular Pokemon GO game more accessible to wheelchair users and others with limited range of motion. 

For the full story and video, click here

Former OBIO CAAP company Eve Medical was highlighted on CBC News. The EVE Kit is gearing up to be ready for purchase online this fall!

"Canadian women may be able to self-administer tests for sexually transmitted infections from the comfort of their own homes, for less than $100." 

CEO Jessica Ching says, the hope is to make "it more convenient for women to test for HPV which could guard against cervical cancer."

Follow their progress and updates on Twitter @evemedical

For the CBC feature click here

Aug 8, 2016 - 4 OBIO Pre-CAAP companies have been selected as winners of the Ontario Brain Institute (OBI) 2016 ONtrepreneurs Program!

Congratulations to  Winterlight Labs, SensOR Medical Laboratory, TopSpin360 & iMerciv!

The ONtrepreneurs (Ontario Neurotech Entrepreneurs) Program helps "Ontario neurotech entrepreneurs take their ideas from the lab to the marketplace."

This year's winners participated in a pitching competition to a panel of "expert judges from organizations including Yocto Law, Biomedical Zone, Emmetros, AGE-WELL, Ironstone Product Development Inc. and OBI."

$300,000 ($50,000 each) has been awarded to the winners to assist with commercializing their neurotechnologies.

For the full press release, click here

AbCelex has been awarded a $3.4 million government investment to help develop a new line of anti-microbial feed additives to help control disease outbreaks in poultry flocks, Agriculture and Agri- Food Canada have reported.

CellAegis autoRIC® Device, which reduces heart damage in ischemic heart disease, is now being clinically implemented in Peel-Halton Region, West of Toronto. The autoRIC® Device is being used to treat all patients having heart attacks, in addition to standard treatment. The FIRST study (Field Implementation of autoRIC Device in STEMI (ST-segment Myocardial Infarction)) is the first clinical implementation of our device across an entire region, and is expected to be the first of many such clinical implementations, as the benefit of Remote Ischemic Conditioning therapy becomes more widely utilized.

For the full press release click here

July 21, 2016 KITCHENER — A startup developing a low-cost, high-resolution digital X-ray imager to detect lung disease in developing nations has received a $1-million boost.

The new money from federally funded Grand Challenges Canada will help KA Imaging build a prototype and test it in the field in Zambia by the end of the year.

For the full article click here

For the Grand Challenges press release, click here

OBIO Innovation Agenda Leader

On July 21st, Gail Garland, CEO of OBIO attended the  Federal Government's Global Science Excellence Roundtable, part of the Inclusive Innovation Agenda Strategy held in Ottawa.

The ideas generated during the session will be consolidated and presented to Minister Navdeep Bains for consideration as part of the Inclusive Innovation Agenda report.

For the full report, click here

For the Innovation Submission page, click here

July 19, 2016 TORONTO – iTP Biomedica Corp., a developer of proprietary whole transcriptome-based cancer diagnostics, today announced the launch of BladderPredict, a groundbreaking next-generation sequencing-based test that will for the first time assist uro-pathologists in assigning disease grade in early stage bladder cancer, and urologists and uro-oncologists in managing the disease.

For the full press release, click here

July 7, 2016 - TranQool. an online platform that matches users with registered Cognitive Behavioural Therapy (CBT) therapists and lets them connect via secure video calls, was featured in Canadian Healthcare Technology magazine.

July 6, 2016 - CAAP Company Eve Medical and their CEO, Jessica Ching, are featured in the August issue of Chatelaine.

June 24, 2016 This year Toronto hosted the inaugural RESI conference on June 23, bringing together hundreds of companies and investors from across the globe in areas of biotech, digital health, medical devices and consumer health. 

June 14, 2016 - OBIO's own Dr. Klaus Fiebig, Senior Director of Strategic Programs, was asked to moderate at this years MedEdge Summit hosted in Richmond Hill.

For the video, click here (See Klaus at 1:55)